It is particularly well-suited for people prioritizing sleep optimization and recovery, those interested in anti-aging and longevity, patients who want a gentler approach to GH support, individuals looking for overall wellness improvement rather than targeted fat loss, and those who prefer a peptide with a well-established safety profile
Headache with weakness, numbness, difficulty speaking, or facial asymmetry
CJC-1295 Tesamorelin : Typically administered daily at doses ranging from 1-2 mg
Retatrutide is an investigational triple-receptor agonist that activates GIP, GLP-1 and glucagon receptors
Wellness uses are rarely covered by insurance
Most patients see more noticeable weight reduction by the 8- to 12-week mark